Return of Results

Return to Projects Page.

The purpose of defining returnable results is to define a set of genetic variants that are believed to be useful in clinical practice for purposes, such as assessment of genetic risk for complex disorders or the selection and dosing of drugs. Currently, the eMERGE Network has identified an initial set of variants that focus on common diseases and pharmacogenomics variants. The level of evidence supporting each variant along with the cost and benefit of incorporating them into patient care will be considered. Other areas of interest include genetic risk scores and susceptibility variants.

Return of results-related publications


In the News

Here's what's happening with eMerge:


The Electronic Medical Records & Genomics (eMERGE) Network is thrilled to be represented by our investigators at the American Medical Informatics Association (AMIA) Annual Symposium, hosted November...


An upcoming scheduled maintenance window is starting Tuesday, September 5th and ending Wednesday, September 6th. During this time, the RD Discover, SD Discover, Subject Locator and Record Counter applications...


The NIH/NHGRI has published IGNITE II RFAs which are linked below for your convenience.

  • Implementing Genomics in Practice (IGNITE) II: Pragmatic Clinical Trials – Clinical Groups...


CMS announced last week it will award up to $30 million in grant funding to clinical specialty societies, clinical professional organizations and independent research organizations to develop quality measures...